We are live on ! Find out more
NHS.RT icon

Neuberger High Yield Strategies Fund Rights
NHS.RT

Delisted

NHS.RT was delisted on the 14th of April, 2026.

0 hedge funds and large institutions have $0 invested in Neuberger High Yield Strategies Fund Rights in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 45 → 0 (-45)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $46.1K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 44

Holders
–
Holders Change
-45
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
44
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

NHS.RT Hedge Fund Activity: Q2 2026 in Review

0 of the 8,395 institutional investors tracked by Wall St. Rank reported a position in Neuberger High Yield Strategies Fund Rights (NHS.RT) for Q2 2026, worth a combined $0 — down 100% from $46.1K a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of NHS.RT and 0 opened new positions — a net loss of 44 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $5.14K sold.

  • 0 institutional investors held Neuberger High Yield Strategies Fund Rights (NHS.RT) as of Q2 2026, down from 45 in Q1 2026.
  • Funds reported $0 of Neuberger High Yield Strategies Fund Rights stock for Q2 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Neuberger High Yield Strategies Fund Rights positions in Q2 2026 and 44 closed out, a net change of -44 holders.
  • The largest Neuberger High Yield Strategies Fund Rights seller in Q2 2026 was Morgan Stanley, an estimated $5.14K sold.

Based on aggregated 13F filings for Q2 2026.